Little evidence for lethal reperfusion injury to cardiomyocytes

Journal of Thrombosis and Thrombolysis

Volumn 4, Issue 1, 1997, Pages 111-112

  Heusch, Gerd ^a   Schulz, Rainer ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 0031025651     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1017591610591     Document Type: Article

References (13)

1. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs. duration of coronary occlusion in dogs. Circulation 1977;56:786-794.
2. Klein HH, Puschmann S, Schaper J, Schaper W. The mechanism of the tetrazolium reaction in identifying experimental myocardial infarction. Virchows Arch 1981;393:287-297.
3. Schaper J. Myocardial ultrastructure in ischemia. In Heusch G, ed. Pathophysiology and Rational Pharmacotherapy of Mycardial Ischemia. New York: Steinkopff and Springer Verlag, 1990:11-36.
4. Jennings RB, Schaper J, Hill ML, Steenbergen CJ, Reimer KA. Effect of reperfusion late in the phase of reversible ischemic injury. Changes in cell volume, electrolytes, metabolites, and ultrastructure. Circ Res 1985;56:262-278.
5. Ganz W, Watanabe I, Kanamasa K, Yano J, Han D-S, Fishbein MC. Does reperfusion extend necrosis? A study in a single territory of myocardial ischemia-half reperfused and half not reperfused. Circulation 1990;82: 1020-1033.
6. Hofmann M, Genth K, Schaper W. The influence of reperfusion on infarct size after experimental coronary artery occlusion. Basic Res Cardiol 1980;75:572-582.
7. Braunwald E. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded? Circulation 1989;79:441-444.
8. Schaper W, Gorge G, Winkler B, Schaper J. The collateral circulation of the heart. Prog Cardiovasc Dis 1988;13: 57-77.
9. Jolly SK, Kane WJ, Bailie MB, Abrams GD, Lucchesi BR. Canine myocardial reperfusion injury its reduction by the combined administration of superoxide dismutase and catalase. Circ Res 1984;54:277-285.
10. Ambrosio G, Becker LC, Hutchins GM, Weisman HF, Weisfeldt ML. Reduction in experimental infarct size by recombinant human superoxide dismutase: Insights into the pathophysiology of reperfusion injury. Circulation 1986;74: 1424-1433.
11. Przyklenk K, Kloner RA. "Reperfusion injury" by oxygen-derived free radicals? Effect of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow. Circ Res 1989;64: 86-96.
12. Shirato C, Miura T, Ooiwa H, Toyofuku T, Wilborn WH, Downey JM. Tetrazolium artifactually indicates superoxide dismutase-induced salvage in reperfused rabbit heart. J Mol Cell Cardiol 1989;21:1187-1193.
13. Klein HH, Pich S, Lindert S, Nebendahl K, Warneke G, Kreuzer H. Treatment of reperfusion injury intracoronary calcium channel antagonists and reduced coronary free calcium concentration in regionally ischemic, reperfused porcine hearts. J Am Coll Cardiol 1989;13:1395-1401.